Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
IASLC Academy
IASLC Academy
Amazing Case Race 2024
Publications, Resources & Guidelines
News
News
ILCN
WCLC 2024 News
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 229 - 240 items out of 285 results
ILCN article
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
ILCN article
MARIPOSA-2 Post-progression Analysis Favors Amivantamab-Chemotherapy Combination
ILCN article
Can Artificial Intelligence Identify Those at High Risk and Shift the Lung Cancer Screening Paradigm?
ILCN article
Mounting Evidence Supporting Neoadjuvant ChemoIO Means Surgeons Must Adapt
ILCN article
More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care
ILCN article
A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib
ILCN article
Patient Perspective: Patients With EGFR+ NSCLC May Still Opt for Quality Over Quantity After FLAURA2
ILCN article
Transporting Real-World Evidence Between Countries—Ready to Beam Aboard?
ILCN article
Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds
ILCN article
Modified Lung Cancer Screening Eligibility Requirements May Reduce Racial Disparities in Lung Cancer Screening, Treatment
ILCN article
Mesothelioma Patients Experienced Higher Levels of Toxicity on CheckMate743 Regimen Than Reported in Clinical Trials
ILCN article
Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC
Pagination
First
First page
‹
Previous page
…
16
17
18
19
20
21
22
23
24
›
Next page
Last
Last page